Amicus Therapeutics, Inc. (FOLD)
NASDAQ: FOLD · Real-Time Price · USD
14.34
+0.01 (0.03%)
Mar 6, 2026, 1:43 PM EST - Market open
Amicus Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 634.21 | 528.3 | 399.36 | 329.23 | 305.51 | Upgrade
|
| Revenue Growth (YoY) | 20.05% | 32.29% | 21.30% | 7.76% | 17.11% | Upgrade
|
| Cost of Revenue | 72.93 | 52.94 | 37.33 | 38.6 | 34.47 | Upgrade
|
| Gross Profit | 561.28 | 475.35 | 362.03 | 290.63 | 271.05 | Upgrade
|
| Selling, General & Admin | 383.49 | 323.38 | 275.27 | 213.04 | 192.71 | Upgrade
|
| Research & Development | 135.84 | 109.36 | 152.38 | 276.68 | 272.05 | Upgrade
|
| Operating Expenses | 526.79 | 441.29 | 435.52 | 495.06 | 470.97 | Upgrade
|
| Operating Income | 34.49 | 34.06 | -73.49 | -204.43 | -199.92 | Upgrade
|
| Interest Expense | -46.16 | -49.6 | -50.15 | -37.12 | -32.47 | Upgrade
|
| Interest & Investment Income | 3.32 | 5.41 | 7.08 | 3.02 | 0.51 | Upgrade
|
| Other Non Operating Income (Expenses) | 10.24 | -9.44 | -15.89 | 4.18 | -2.9 | Upgrade
|
| EBT Excluding Unusual Items | 1.89 | -19.57 | -132.45 | -234.35 | -234.78 | Upgrade
|
| Merger & Restructuring Charges | - | -9.19 | - | - | - | Upgrade
|
| Asset Writedown | -1.7 | - | -1.13 | -6.62 | - | Upgrade
|
| Other Unusual Items | - | - | -16.52 | -1.08 | -6.77 | Upgrade
|
| Pretax Income | 0.19 | -28.76 | -150.1 | -242.04 | -241.55 | Upgrade
|
| Income Tax Expense | 27.3 | 27.35 | 1.48 | -5.47 | 8.91 | Upgrade
|
| Net Income | -27.11 | -56.11 | -151.58 | -236.57 | -250.46 | Upgrade
|
| Net Income to Common | -27.11 | -56.11 | -151.58 | -236.57 | -250.46 | Upgrade
|
| Shares Outstanding (Basic) | 308 | 304 | 295 | 289 | 271 | Upgrade
|
| Shares Outstanding (Diluted) | 308 | 304 | 295 | 289 | 271 | Upgrade
|
| Shares Change (YoY) | 1.31% | 3.12% | 2.11% | 6.50% | 4.85% | Upgrade
|
| EPS (Basic) | -0.09 | -0.18 | -0.51 | -0.82 | -0.92 | Upgrade
|
| EPS (Diluted) | -0.09 | -0.18 | -0.51 | -0.82 | -0.92 | Upgrade
|
| Free Cash Flow | 29.85 | -37.44 | -76.53 | -170.34 | -206.38 | Upgrade
|
| Free Cash Flow Per Share | 0.10 | -0.12 | -0.26 | -0.59 | -0.76 | Upgrade
|
| Gross Margin | 88.50% | 89.98% | 90.65% | 88.28% | 88.72% | Upgrade
|
| Operating Margin | 5.44% | 6.45% | -18.40% | -62.09% | -65.44% | Upgrade
|
| Profit Margin | -4.28% | -10.62% | -37.96% | -71.85% | -81.98% | Upgrade
|
| Free Cash Flow Margin | 4.71% | -7.09% | -19.16% | -51.74% | -67.55% | Upgrade
|
| EBITDA | 41.95 | 42.61 | -65.62 | -199.08 | -193.71 | Upgrade
|
| EBITDA Margin | 6.62% | 8.07% | -16.43% | -60.47% | -63.41% | Upgrade
|
| D&A For EBITDA | 7.46 | 8.55 | 7.87 | 5.34 | 6.21 | Upgrade
|
| EBIT | 34.49 | 34.06 | -73.49 | -204.43 | -199.92 | Upgrade
|
| EBIT Margin | 5.44% | 6.45% | -18.40% | -62.09% | -65.44% | Upgrade
|
| Effective Tax Rate | 14293.72% | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.